Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
590,231,680
-
Number of holders
-
573
-
Total 13F shares, excl. options
-
85,080,106
-
Shares change
-
-5,791,431
-
Total reported value, excl. options
-
$12,117,685,386
-
Value change
-
-$825,149,875
-
Put/Call ratio
-
38.52%
-
Number of buys
-
247
-
Number of sells
-
-256
-
Price
-
$142.43
Significant Holders of Edwards Lifesciences Corp - Common Stock (EW) as of Q2 2015
646 filings reported holding EW - Edwards Lifesciences Corp - Common Stock as of Q2 2015.
Edwards Lifesciences Corp - Common Stock (EW) has 573 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 85,080,106 shares
of 590,231,680 outstanding shares and own 14.41% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (9,351,098 shares), WELLINGTON MANAGEMENT GROUP LLP (5,450,018 shares), Capital Research Global Investors (4,368,000 shares), BlackRock Institutional Trust Company, N.A. (3,248,741 shares), AQR CAPITAL MANAGEMENT LLC (2,402,485 shares), FMR LLC (2,022,440 shares), GENERATION INVESTMENT MANAGEMENT LLP (1,971,195 shares), BlackRock Fund Advisors (1,934,161 shares), Bank of New York Mellon Corp (1,835,672 shares), and JANUS CAPITAL MANAGEMENT LLC (1,722,575 shares).
This table shows the top 573 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.